Cover Image
市場調查報告書

胰臟癌診斷產品:開發平台分析

Pancreatic Cancer - Pipeline Review, 2015

出版商 GlobalData 商品編碼 342289
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
Back to Top
胰臟癌診斷產品:開發平台分析 Pancreatic Cancer - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 107 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的胰臟癌診斷用診斷產品 (及相關產品) 之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 胰臟癌診斷產品概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各核審時期 (估計)

第4章 胰臟癌診斷產品:正在開發的開發中產品 (各企業)

  • 胰臟癌診斷產品的開發企業:開發中產品 (各開發階段)
  • 胰臟癌診斷產品:各開發階段的開發中產品一覽

第5章 胰臟癌診斷產品的開發企業·產品概要

  • A&G Pharmaceutical, Inc.
    • 開發中產品及現在進行中的臨床實驗概要
  • Abcodia Ltd.
  • Acobiom
  • Andraka Technologies, LLC
  • Applied Proteomics, Inc.
  • Asuragen, Inc.
  • BioMarker Strategies, LLC
  • Biouniversa s.r.l.
  • Cancer Research Technology Limited
  • Cellmid Limited
  • Cepheid
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • Clovis Oncology, Inc.
  • CompanDX Ltd.
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Dartmouth College
  • Di.V.A.L Toscana srl
  • Exact Sciences Corporation
  • GeneFluidics Inc.
  • German Cancer Research Center
  • GlycoZym
  • Health Discovery Corporation
  • Hebrew University of Jerusalem
  • ImmunoCellular Therapeutics, Ltd.
  • Immunomedics, Inc.
  • Imperial College London
  • IV Diagnostics, Inc.
  • Matrix-Bio, Inc.
  • Mayo Clinic
  • MDNA Life Sciences, Inc.
  • Merrimack Pharmaceuticals, Inc.
  • Metanomics Health GmbH
  • Milagen, Inc.
  • Miraculins Inc.
  • NanoScale Corporation
  • NatiMab Therapeutics S.r.l.
  • National Cheng-Kung University Hospital
  • Neogenix Oncology, Inc.
  • Onconome, Inc.
  • OPKO Health, Inc.
  • Oxford Gene Technology Limited
  • PeriRx LLC
  • Precision Biologics, Inc.
  • Proplex Technologies, Llc
  • Protagen AG
  • SDIX, LLC
  • Sienna Cancer Diagnostics Ltd
  • SomaLogic, Inc.
  • Source MDx
  • Stanford University
  • The Johns Hopkins University
  • Thomas Jefferson University
  • US Biomarkers, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.

第6章 胰臟癌診斷產品:近來的市場趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0072EPD

GlobalData's Medical Devices sector report, "Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Pancreatic Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Pancreatic Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Pancreatic Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Pancreatic Cancer Overview

3. Products under Development

  • 3.1. Pancreatic Cancer - Pipeline Products by Stage of Development
  • 3.2. Pancreatic Cancer - Pipeline Products by Territory
  • 3.3. Pancreatic Cancer - Pipeline Products by Regulatory Path
  • 3.4. Pancreatic Cancer - Pipeline Products by Estimated Approval Date

4. Pancreatic Cancer - Pipeline Products under Development by Companies

  • 4.1. Pancreatic Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Pancreatic Cancer - Pipeline Products by Stage of Development

5. Pancreatic Cancer Companies and Product Overview

  • 5.1. A&G Pharmaceutical, Inc. Company Overview
    • 5.1.1. A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Abcodia Ltd. Company Overview
    • 5.2.1. Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Acobiom Company Overview
    • 5.3.1. Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Andraka Technologies, LLC Company Overview
    • 5.4.1. Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Applied Proteomics, Inc. Company Overview
    • 5.5.1. Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Asuragen, Inc. Company Overview
    • 5.6.1. Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BioMarker Strategies, LLC Company Overview
    • 5.7.1. BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Biouniversa s.r.l. Company Overview
    • 5.8.1. Biouniversa s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Cancer Research Technology Limited Company Overview
    • 5.9.1. Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Cellmid Limited Company Overview
    • 5.10.1. Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Cepheid Company Overview
    • 5.11.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Chronix Biomedical, Inc. Company Overview
    • 5.12.1. Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Cleveland Diagnostics Inc. Company Overview
    • 5.13.1. Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Clovis Oncology, Inc. Company Overview
    • 5.14.1. Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. CompanDX Ltd. Company Overview
    • 5.15.1. CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Courtagen Life Sciences, Inc. Company Overview
    • 5.16.1. Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. CS-Keys, Inc. Company Overview
    • 5.17.1. CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Dartmouth College Company Overview
    • 5.18.1. Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Di.V.A.L Toscana srl Company Overview
    • 5.19.1. Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Exact Sciences Corporation Company Overview
    • 5.20.1. Exact Sciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. GeneFluidics Inc. Company Overview
    • 5.21.1. GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. German Cancer Research Center Company Overview
    • 5.22.1. German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. GlycoZym Company Overview
    • 5.23.1. GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Health Discovery Corporation Company Overview
    • 5.24.1. Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Hebrew University of Jerusalem Company Overview
    • 5.25.1. Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. ImmunoCellular Therapeutics, Ltd. Company Overview
    • 5.26.1. ImmunoCellular Therapeutics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Immunomedics, Inc. Company Overview
    • 5.27.1. Immunomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Imperial College London Company Overview
    • 5.28.1. Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. IV Diagnostics, Inc. Company Overview
    • 5.29.1. IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Matrix-Bio, Inc. Company Overview
    • 5.30.1. Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Mayo Clinic Company Overview
    • 5.31.1. Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. MDNA Life Sciences, Inc. Company Overview
    • 5.32.1. MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Merrimack Pharmaceuticals, Inc. Company Overview
    • 5.33.1. Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Metanomics Health GmbH Company Overview
    • 5.34.1. Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Milagen, Inc. Company Overview
    • 5.35.1. Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. Miraculins Inc. Company Overview
    • 5.36.1. Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. NanoScale Corporation Company Overview
    • 5.37.1. NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. NatiMab Therapeutics S.r.l. Company Overview
    • 5.38.1. NatiMab Therapeutics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. National Cheng-Kung University Hospital Company Overview
    • 5.39.1. National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Neogenix Oncology, Inc. Company Overview
    • 5.40.1. Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Onconome, Inc. Company Overview
    • 5.41.1. Onconome, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. OPKO Health, Inc. Company Overview
    • 5.42.1. OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Oxford Gene Technology Limited Company Overview
    • 5.43.1. Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. PeriRx LLC Company Overview
    • 5.44.1. PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Precision Biologics, Inc. Company Overview
    • 5.45.1. Precision Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Proplex Technologies, Llc Company Overview
    • 5.46.1. Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. Protagen AG Company Overview
    • 5.47.1. Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. SDIX, LLC Company Overview
    • 5.48.1. SDIX, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. Sienna Cancer Diagnostics Ltd Company Overview
    • 5.49.1. Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. SomaLogic, Inc. Company Overview
    • 5.50.1. SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. Source MDx Company Overview
    • 5.51.1. Source MDx Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. Stanford University Company Overview
    • 5.52.1. Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. The Johns Hopkins University Company Overview
    • 5.53.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Thomas Jefferson University Company Overview
    • 5.54.1. Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. US Biomarkers, Inc. Company Overview
    • 5.55.1. US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.56. Viomics Inc. Company Overview
    • 5.56.1. Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.57. Vitatex Inc. Company Overview
    • 5.57.1. Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.58. VolitionRX Ltd. Company Overview
    • 5.58.1. VolitionRX Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Pancreatic Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pancreatic Cancer - Pipeline Products by Stage of Development
  • Table 2: Pancreatic Cancer - Pipeline Products by Territory
  • Table 3: Pancreatic Cancer - Pipeline Products by Regulatory Path
  • Table 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Pancreatic Cancer Companies - Pipeline Products by Stage of Development
  • Table 6: Pancreatic Cancer - Pipeline Products by Stage of Development
  • Table 7: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Companion Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 9: Companion Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 10: Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 12: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Companion Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 15: Companion Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 16: Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 18: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 19: Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: API Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 21: API Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 22: Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: miRNA Pancreatic Cancer Test - Product Status
  • Table 24: miRNA Pancreatic Cancer Test - Product Description
  • Table 25: BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Status
  • Table 27: Ex Vivo Biomarker Test - Pancreatic Cancer - Product Description
  • Table 28: Biouniversa s.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: BAG3 ELISA Kit - Pancreatic Cancer Diagnosis - Product Status
  • Table 30: BAG3 ELISA Kit - Pancreatic Cancer Diagnosis - Product Description
  • Table 31: BAG3 ELISA Kit - Pancreatic Cancer Early Diagnosis - Product Status
  • Table 32: BAG3 ELISA Kit - Pancreatic Cancer Early Diagnosis - Product Description
  • Table 33: Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: IHC Based Test - Pancreatic Cancer - Product Status
  • Table 35: IHC Based Test - Pancreatic Cancer - Product Description
  • Table 36: Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: MK Pan Cancer Marker Assay - Product Status
  • Table 38: MK Pan Cancer Marker Assay - Product Description
  • Table 39: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Xpert Pancreatic CA Monitor Assay - Product Status
  • Table 41: Xpert Pancreatic CA Monitor Assay - Product Description
  • Table 42: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Companion Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 44: Companion Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 45: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Blood-Based Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 47: Blood-Based Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 48: Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: hENT1 Companion Diagnostic Test - Product Status
  • Table 50: hENT1 Companion Diagnostic Test - Product Description
  • Table 51: CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Biomarker Assay - Pancreatic Cancer - Product Status
  • Table 53: Biomarker Assay - Pancreatic Cancer - Product Description
  • Table 54: Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 55: Pancreatic Cancer Diagnostic Panel - Product Status
  • Table 56: Pancreatic Cancer Diagnostic Panel - Product Description
  • Table 57: CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: caPCNA - Pancreatic Cancer - Product Status
  • Table 59: caPCNA - Pancreatic Cancer - Product Description
  • Table 60: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: ISH/IHC Assay - Pancreatic Cancer - Product Status
  • Table 62: ISH/IHC Assay - Pancreatic Cancer - Product Description
  • Table 63: Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: NanoMabKv - Pancreatic Cancer - Product Status
  • Table 65: NanoMabKv - Pancreatic Cancer - Product Description
  • Table 66: Exact Sciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 68: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 69: GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: CA 19-9 Assay - Product Status
  • Table 71: CA 19-9 Assay - Product Description
  • Table 72: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 74: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 75: GlycoZym Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 77: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 78: Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 80: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 81: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 83: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 84: ImmunoCellular Therapeutics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 86: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 87: Immunomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 89: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 90: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Prognostic Assay - Pancreatic Cancer - Product Status
  • Table 92: Prognostic Assay - Pancreatic Cancer - Product Description
  • Table 93: IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 95: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 96: Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: VeraMarker Pancreatic Cancer Test - Product Status
  • Table 98: VeraMarker Pancreatic Cancer Test - Product Description
  • Table 99: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: Methylation Biomarker Test - Pancreatic Cancer - Product Status
  • Table 101: Methylation Biomarker Test - Pancreatic Cancer - Product Description
  • Table 102: MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 104: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 105: Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 107: MM-141 Companion Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 108: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 110: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 111: Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: Immunoassay - Pancreatic Cancer - Product Status
  • Table 113: Immunoassay - Pancreatic Cancer - Product Description
  • Table 114: Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 116: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 117: NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 119: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 120: NatiMab Therapeutics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 121: Diagnostic Test - Pancreas Adenocarcinoma - Product Status
  • Table 122: Diagnostic Test - Pancreas Adenocarcinoma - Product Description
  • Table 123: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: Diagnostic Biomarker - Pancreatic Cancer - Product Status
  • Table 125: Diagnostic Biomarker - Pancreatic Cancer - Product Description
  • Table 126: Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 127: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 128: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 129: Onconome, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 130: Pan Cancer Screening and Detection Test - Product Status
  • Table 131: Pan Cancer Screening and Detection Test - Product Description
  • Table 132: Pan-Cancer Metastatic Marker Test - Product Status
  • Table 133: Pan-Cancer Metastatic Marker Test - Product Description
  • Table 134: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 136: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 137: Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 138: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 139: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 140: PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 141: Saliva Test - Pancreatic Cancer - Product Status
  • Table 142: Saliva Test - Pancreatic Cancer - Product Description
  • Table 143: Precision Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 144: NEO-301 IHC Test - Product Status
  • Table 145: NEO-301 IHC Test - Product Description
  • Table 146: Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 147: Biomarker Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 148: Biomarker Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 149: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 150: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 151: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 152: SDIX, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 153: Pancreatic Cancer Assay - Product Status
  • Table 154: Pancreatic Cancer Assay - Product Description
  • Table 155: Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 156: Sienna Test - Pancreatic Cancer - Product Status
  • Table 157: Sienna Test - Pancreatic Cancer - Product Description
  • Table 158: SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 159: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 160: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 161: Source MDx Pipeline Products & Ongoing Clinical Trials Overview
  • Table 162: Precision Profile - Pancreatic Cancer - Product Status
  • Table 163: Precision Profile - Pancreatic Cancer - Product Description
  • Table 164: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 165: Biomarker Assay - Pancreatic Cyst - Product Status
  • Table 166: Biomarker Assay - Pancreatic Cyst - Product Description
  • Table 167: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 168: Antigen Based Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 169: Antigen Based Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 170: Protein Biomarker Assay - Pancreatic Cancer - Product Status
  • Table 171: Protein Biomarker Assay - Pancreatic Cancer - Product Description
  • Table 172: Protein Biomarker Assay - Pancreatic Cancer - Product Status
  • Table 173: Protein Biomarker Assay - Pancreatic Cancer - Product Description
  • Table 174: Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 175: Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 176: Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 177: US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 178: Blood-Based Biomarker - Pancreatic Cancer - Product Status
  • Table 179: Blood-Based Biomarker - Pancreatic Cancer - Product Description
  • Table 180: Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 181: Viomics Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 182: Viomics Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 183: Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 184: Pancreatic Cancer CTC Detection Kit - Product Status
  • Table 185: Pancreatic Cancer CTC Detection Kit - Product Description
  • Table 186: VolitionRX Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 187: NuQ Diagnostic Test - Pancreatic Cancer - Product Status
  • Table 188: NuQ Diagnostic Test - Pancreatic Cancer - Product Description
  • Table 189: Glossary

List of Figures

  • Figure 1: Pancreatic Cancer - Pipeline Products by Stage of Development
  • Figure 2: Pancreatic Cancer - Pipeline Products by Territory
  • Figure 3: Pancreatic Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Pancreatic Cancer - Pipeline Products by Estimated Approval Date
Back to Top